1. Pearle MS, Calhoun EA, Curhan GC. Urologic Diseases of AmericaProject. Urologic diseases in America project: urolithiasis. J Urol.2005;173(3):848-857.
2. Liu Y, Chen Y, Liao B, et al. Epidemiology of urolithiasis in Asia. AsianJ Urol. 2018;5(4):205-214.
3. Table 14-47. Economic impact of urologic disease. In: Litwin MS, SaigalCS, eds. Urologic Diseases in America. US Department of Health andHuman Services, Public Health Service, National Institutes of Health,National Institute of Diabetes and Digestive and Kidney Diseases.Washington, DC: US Government Printing Office 486. NIH Publication2012;12-7865.
4. 4. Fink HA, Wilt TJ, Eidman KE, et al. Recurrent Nephrolithiasis inAdults: comparative Effectiveness of Preventive Medical Strategies.Rockville, MD: Agency for Healthcare Research and Quality;Comparative Effectiveness Review 2012; No. 61. AHRQ Publication No.12-EHC049-EF.
5. 5. Ferrari P, Piazza R, Ghidini N et al. Lithiasis and risk factors. Urol Int.2007;79(Suppl 1):8-15.
6. 6. Aune D, Mahamat-Saleh Y, Norat T, et al. Body fatness, diabetes,physical activity and risk of kidney stones: a systematic review andmeta-analysis of cohort studies. Eur J Epidemiol. 2018;33(11):1033-1047.
7. Najem GR, Seebode JJ, Samady AJ, et al. Stressful life events and risk ofsymptomatic kidney stones. Int J Epidemiol. 1997;26(5):1017-1023.
8. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for theprevention of recurrent stones in idiopathic hypercalciuria. N Engl JMed. 2002;346(2):77-84.
9. Borghi LA, Nouvenne, Meschi T. Nephrolithiasis and urinary tractinfections: ‘the chicken or the egg’ dilemma? Nephrol Dial Transplant.2012;27(11):3982-3984.
10. Shekarriz B, Stoller ML. Uric acid nephrolithiasis: current concepts andcontroversies. J Urol. 2012; 168:1307-1314.
11. Yamasaki A. Long-term results of endourological treatment of urinarycalculi: multivariate analyses of the risk factors related to recurrence orre-growth. Nihon Hinyokika Gakkai Zasshi. 1994;85(1): 1601-1609.
12. Curhan GC, Willet WC, Rimm EB, et al. Family history and risk ofkidney stones. J Am Soc Nephrol. 1997;8(10):1568-1573.
13. Curhan GC, Willet WC, Rimm EB, et al. A prospective study of dietarycalcium and other nutrients and the risk of symptomatic kidney stones.N Engl J Med. 1993;328(12):833-838.
14. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the riskof kidney stones. JAMA. 2005;293(4):455-462.
15. Manzoor H, Saikali SW. Renal Extracorporeal Lithotripsy. StatPearls[Internet]. Treasure Island (FL): StatPearls Publishing. 2021.
16. Pengbo J , Lillian X , Raphael A, et al. Qualitative Review of ClinicalGuidelines for Medical and Surgical Management of Urolithiasis:Consensus and Controversy. J Urol. 2020;205(4):999-1008.
17. Pearle MS, Goldfarb DS, Assimos DG, et al. Medical management ofkidney stones: AUA guideline. J Urol. 2014;192(29):316-324.
18. Skolarikos A, Straub M, Knoll T, et al. Metabolic evaluation andrecurrence prevention for urinary stone patients: EAU Guidelines. EurUrol. 2015;67(4):750-763.
19. Lee YH, Huan, WC, Lu CM, et al. Stone recurrence predictive score(SRPS) for patients with calcium oxalate stones. J Urol. 2003;170(2):404-407.
20. Rule AD, Lieske JC, Li X, et al. The ROKS nomogram forpredicting a second symptomatic stone episode. J Am Soc Nephrol.2014;25(12):2878-2886.
21. Vaughan LE, Enders FT, Lieske JC, et al. Predictors of symptomatickidney stone recurrence after the first and subsequent episodes. MayoClin Proc. 2019;94(2):202-210.
22. Ferrandino MN, Pietrow PK, Preminger GM. Evaluation and medicalmanagement of urinary lithiasis. In:Wein AJ, Kavoussi LR, NovickAC, Partin AW, Peters CA. Campbell-Walsh Urology. Philadelphia:Saunders Elsevier 2012;1287-1302.
23. Ferraro PM, Curhan GC, D’Addessi A, et al. Risk of recurrence ofidiopathic calcium kidney stones: analysis of data from the literature. JNephrol. 2017;30(2):227-233.
24. Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reportedprevalence of kidney stones in the United States: 1976-1994. Kidney Int.2003;63(5):1817-1823.
25. Matlaga BR. The need for better decision tools in managing stonedisease. J Urol. 2012;188(3):698-699.